Ocular Therapeutix Logo

Ocular Therapeutix

🇺🇸
OCUL
US67576A1007

Ocular Therapeutix is a leading US-based biopharmaceutical company specializing in innovative ophthalmology. Leveraging its proprietary hydrogel platform, the company develops sustainable therapies focused on the treatment of serious diseases affecting the ocular surface.

Next Quarterly Earnings

Monday, November 9, 2026
CW 46
Pre-Market
In 74 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 12, 2026

Stock Price

Frequently asked questions

When will Ocular Therapeutix report its next quarterly earnings?

Ocular Therapeutix is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Ocular Therapeutix last report quarterly earnings?

Ocular Therapeutix last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at -0.35 USD.

How often has Ocular Therapeutix beaten expectations?

Ocular Therapeutix has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the Ocular Therapeutix earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.36
Actual:
Q2 2026
Beat
Estimate:-$0.40
Actual:-$0.35
Difference:+$0.05
Price reaction (1 day):+2.8 %
Price reaction (7 days):+13.1 %
Q1 2026
Missed
Estimate:-$0.31
Actual:-$0.40
Difference:-$0.09
Price reaction (1 day):-0.6 %
Price reaction (7 days):-6.2 %
Q3 2025
Beat
Estimate:-$0.34
Actual:-$0.29
Difference:+$0.05
Q2 2025
Missed
Estimate:-$0.35
Actual:-$0.38
Difference:-$0.03
Q1 2025
Missed
Estimate:-$0.36
Actual:-$0.39
Difference:-$0.04

Earnings statistics

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
-3.1%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Ocular Therapeutix
Ticker Symbol
OCUL
ISIN
US67576A1007
Country
🇺🇸
USA
Sector